Innovative Industrial Properties (IIPR) investor relations material

Executive summary

• Diversified REIT with $2.5B invested capital, operating across cannabis and life sciences in 19 U.S. states with 111 properties and over 35 tenants.

• 2025 marked by disciplined execution, strong balance sheet, and strategic repositioning for long-term growth.

• Achieved total revenues of $266.0 million and net income attributable to common stockholders of $114.4 million, or $3.93 per diluted share for 2025.

• Returned over $1.1 billion to shareholders through dividends since inception, with $7.60 per share declared for 2025.

• Strategic $270 million investment in life sciences via IQHQ, enhancing sector diversification and expected to be accretive to AFFO per share.

Financial highlights

• Total revenues for 2025 were $266 million; AFFO reached $205.4 million, or $7.24 per diluted share.

• Q4 2025 revenues were $66.7 million; AFFO was $53.3 million ($1.88/share), with net income of $30.7 million.

• AFFO per share (annualized Q4 2025): $7.52; dividends per share (annualized Q4 2025): $7.60.

• Exited 2025 with liquidity exceeding $105 million, including cash and credit facilities.

• Gross debt: $393.7 million; preferred equity: $50.5 million; debt to total gross assets: 14%.

Outlook and guidance

• Raised over $40 million of preferred stock in early 2026 at a yield just over 9.5%.

• Committed to funding up to an additional $120 million in preferred equity to IQHQ through 2027.

• U.S. legal cannabis market projected to grow at 7% CAGR from 2024–2029, reaching $44 billion by 2029.

• Life sciences R&D expenditures have grown 7% annually from 2014–2024; sector expected to continue strong growth.

• Expect continued strong leasing activity and resolution of non-performing assets to drive earnings upside in future quarters.